Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT05498740

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05498740
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05498740. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-04 (actual); primary completion 2022-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia
Acronym
UltraFuture I
Condition
Peripheral Arterial Disease (PAD)
Intervention (Device)
Drug eluting Balloon
Lead sponsor
Zhejiang Zylox Medical Device Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05498740
Content hash
e650466ea0a93c159f011ba385b807bb85e36b14c4c0e2c3289252fd22ea1d9d